Brief: Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026
26/08/2026 10:47
BRIEF-Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026 Aug 26 (Reuters) - Touyun Biotech Group Ltd 1332.HK:
SEES HK$180 MILLION-HK$200 MILLION PROFIT AND TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE FOR SIX MONTHS ENDED JUNE 30, 2026
EXPECTED HY PROFIT INCREASE MAINLY DUE TO HK$340 MILLION FAIR VALUE GAIN ON FINANCIAL ASSETS
Further company coverage: 1332.HK
((reuters.briefs@thomsonreuters.com))
Recent news on Touyun Biotech
See all newsHong Kong's Touyun Biotech profit surges on fair value gains
Brief: Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026
Brief: Touyun Biotech To Issue 123 Million New Shares At Hk$0.122 Per Share
Brief: Touyun Biotech Appoints Zhou Ruijuan As Executive Director And Vice Chairlady
Brief: Touyun Biotech Group Posts FY Revenue HKD 67 Million